Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Maternal exposure to polycyclic aromatic hydrocarbons diminishes murine ovarian reserve via induction of Harakiri
Andrea Jurisicova, Asako Taniuchi, Han Li, Yuan Shang, Monica Antenos, Jacqui Detmar, Jing Xu, Tiina Matikainen, Adalberto Benito Hernández, Gabriel Nunez, Robert F. Casper
Andrea Jurisicova, Asako Taniuchi, Han Li, Yuan Shang, Monica Antenos, Jacqui Detmar, Jing Xu, Tiina Matikainen, Adalberto Benito Hernández, Gabriel Nunez, Robert F. Casper
View: Text | PDF
Research Article Reproductive biology

Maternal exposure to polycyclic aromatic hydrocarbons diminishes murine ovarian reserve via induction of Harakiri

  • Text
  • PDF
Abstract

Maternal smoking during pregnancy is associated with a variety of adverse neonatal outcomes including altered reproductive performance. Herein we provide molecular evidence for a pathway involved in the elimination of the female germline due to prepregnancy and/or lactational exposure to polycyclic aromatic hydrocarbons (PAHs), environmental toxicants found in cigarette smoke. We show that ovaries of offspring born to mice exposed to PAHs contained only a third of the ovarian follicle pool compared with offspring of unexposed female mice. Activation of the cell death pathway in immature follicles of exposed females was mediated by the aryl hydrocarbon receptor (Ahr), as ovarian reserve was fully rescued by maternal cotreatment with the Ahr antagonist, resveratrol, or by inactivation of the Ahr gene. Furthermore, in response to PAHs, Ahr-mediated activation of the harakiri, BCL2 interacting protein (contains only BH3 domain), was necessary for execution of cell death. This pathway appeared to be conserved between mouse and human, as xenotransplanted human ovarian cortex exposed to PAHs responded by activation of the identical cell death cascade. Our data indicate that maternal exposure to PAHs prior to pregnancy and/or during lactation compromises ovarian reserve of female offspring, raising the concern about the transgenerational impact of maternal smoking on ovarian function in the human.

Authors

Andrea Jurisicova, Asako Taniuchi, Han Li, Yuan Shang, Monica Antenos, Jacqui Detmar, Jing Xu, Tiina Matikainen, Adalberto Benito Hernández, Gabriel Nunez, Robert F. Casper

×

Figure 4

Regulation of Hrk expression in Bax-deficient mouse ovaries and in human ovarian cortical strips.

Options: View larger image (or click on image) Download as PowerPoint
Regulation of Hrk expression in Bax-deficient mouse ovaries and in human...
(A) Induction of Bax expression in ovaries of 3-week-old littermates exposed to vehicle only or PAH treatment prior to pregnancy and during lactation. While Bax induction was evident in both primordial and primary follicles (arrows) in wild-type ovaries upon PAH exposure, induction was not evident in the Hrk-deficient females. Note that larger follicles with several layers of granulosa cells also abundantly expressed Bax. However, this expression was regulated by gonadotropins and was independent of PAH treatment. Images are representative results of at least 3 different animals/genotype/treatment. (B) Hrk-deficient neonatal ovaries failed to upregulate Bax transcript expression in response to in vitro exposure to PAHs over a 24-hour period. The expression data are shown as fold change in PAH-treated versus vehicle-treated ovary from the same female (mean ± SEM) and were obtained from 7 sets of independent ovaries per treatment/genotype. PAH induced a significantly different response between wild-type and Hrk-deficient ovaries (P = 0.035). (C) PAHs induce Hrk expression in human primary (set 1) and primordial (set 2) follicles in ex vivo model. Representative images of immunohistochemical analysis of Hrk protein levels, evidenced by brown staining, in follicles of ovarian grafts 48 hours after exposure to vehicle, PAH, or PAH and resveratrol. Follicles exposed to PAHs have abnormal shrinking morphology typical of degenerating apoptotic follicles. Induction of Hrk was observed primarily in the granulosa cells (arrows) as well as in the surrounding stroma and was almost completely abolished in both cell types by cotreatment with resveratrol (magnification, ×1,000). Data shown are representative results observed from 2 independent sets of experiments using tissues from 2 different patients. No immunoreactivity was observed when primary antibody was omitted (data not shown).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts